Axsome Therapeutics AXSM Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Axsome Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's operating margin?
- Axsome Therapeutics (AXSM) reported operating margin of -24.4% in Q1 2026.
- How has Axsome Therapeutics's operating margin changed year-over-year?
- Axsome Therapeutics's operating margin increased by 60.9% year-over-year, from -62.5% to -24.4%.
- What is the long-term trend for Axsome Therapeutics's operating margin?
- Over 3 years (2022 to 2025), Axsome Therapeutics's operating margin has grown at a -58.3% compound annual growth rate (CAGR), from -359.3% to -26.1%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.